SBIJI Innovation Oct 22, 20201 minAdicet Announces FDA Clearance of IND Application for the Allogeneic CAR Gamma-Delta T Cell TherapyPhase 1 Clinical Study will Evaluate ADI-001 Safety and Efficacy in Patients with B-cell non-Hodgkin’s lymphoma MENLO PARK, Calif. and...
SBIJI Innovation Sep 29, 20201 minOrasis Raises $30 Million to Advance the Clinical Development of Novel Treatment for PresbyopiaOrasis Advances Presbyopia Candidate to Phase 3 Clinical Trials HERZLIYA, Israel, September 10, 2020 – Orasis Pharmaceuticals, an...
SBIJI Innovation Sep 29, 20201 minAyala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101Ayala Pharmaceuticals Presents Positive Interim Data from Phase 2 ACCURACY Trial of AL101 for the treatment of Recurrent/Metastatic...
SBIJI Innovation Sep 29, 20201 minAdicet Bio, Inc. Announces Proposed Public Offering of Common StockMENLO PARK, Calif. and BOSTON, Sept. 21, 2020 (GLOBE NEWSWIRE) -- Adicet Bio, Inc. (“Adicet”) (Nasdaq: ACET), a biotechnology company...
SBIJI Innovation Aug 20, 20201 minBiosight Granted U.S. FDA Fast Track Designation for BST-236Biosight Granted U.S. FDA Fast Track Designation for BST-236 for the Treatment of Acute Myeloid Leukemia Aug. 04, 2020 Biosight Ltd., a...